Literature DB >> 18612943

Phenols from the roots of Rheum palmatum attenuate chemotaxis in rat hepatic stellate cells.

Yun-Lian Lin1, Ching-Fen Wu, Yi-Tsau Huang.   

Abstract

In liver injury, hepatic stellate cells (HSCs) acquire an activated phenotype, migrate to the injured region in response to chemotactic factors and produce extracellular matrix (ECM) proteins including alpha-smooth muscle actin (alpha-SMA) and collagen in order to repair the damage. HSC-T6, a cell line of rat HSCs, was used in in vitro experiments. TGF-beta1 was used as a chemoattractant. The expression of alpha-SMA was used as a marker of activated hepatic stellate cells and cell migration was assayed with the Transwell method to investigate the active principles of the roots of Rheum palmatum L. (Dahuang), a well-known traditional Chinese herb used for treating liver diseases. Under cell activation and chemotaxis-directed fractionation and purification, four anthraquinones, rhein ( 1), emodin ( 2), chrysophanol ( 3) and physcion ( 4), and four phenylbutanoids, lindleyin ( 5), isolindleyin ( 7), 4-(4'-hydroxyphenyl)-2-butanone 4'- O-beta- D-glucopyranoside ( 8), and 4-(4'-hydroxyphenyl)-2-butanone ( 9), and a stilbene, 3,5,4'-trihydroxystilbene 4'- O-beta- D-glucopyranoside 6'- O-gallate ( 6) were isolated from the active fractions. Among them, compounds 1 and 2 inhibited alpha-SMA expression. However, compounds 3, 4, 6 and 8 attenuated chemotactic migration, but not alpha-SMA expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18612943     DOI: 10.1055/s-2008-1074581

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  6 in total

1.  Yinzhihuang attenuates ANIT-induced intrahepatic cholestasis in rats through upregulation of Mrp2 and Bsep expressions.

Authors:  Qiao-Qun Ou; Xin-Hua Qian; Ding-You Li; You-Xiang Zhang; Xia-Nan Pei; Jin-Wen Chen; Li Yu
Journal:  Pediatr Res       Date:  2015-12-08       Impact factor: 3.756

2.  Metabolomics coupled with proteomics advancing drug discovery toward more agile development of targeted combination therapies.

Authors:  Xijun Wang; Aihua Zhang; Ping Wang; Hui Sun; Gelin Wu; Wenjun Sun; Haitao Lv; Guozheng Jiao; Hongying Xu; Ye Yuan; Lian Liu; Dixin Zou; Zeming Wu; Ying Han; Guangli Yan; Wei Dong; Fangfang Wu; Tianwei Dong; Yang Yu; Shuxiang Zhang; Xiuhong Wu; Xin Tong; Xiangcai Meng
Journal:  Mol Cell Proteomics       Date:  2013-01-29       Impact factor: 5.911

3.  Inhibition of mechanical stress-induced hypertrophic scar inflammation by emodin.

Authors:  Cheng Liu
Journal:  Mol Med Rep       Date:  2015-01-28       Impact factor: 2.952

4.  Decreased overall mortality rate with Chinese herbal medicine usage in patients with decompensated liver cirrhosis in Taiwan.

Authors:  Fuu-Jen Tsai; Pei-Yuu Yang; Chao-Jung Chen; Ju-Pi Li; Te-Mao Li; Jian-Shiun Chiou; Chi-Fung Cheng; Po-Heng Chuang; Ting-Hsu Lin; Chiu-Chu Liao; Shao-Mei Huang; Bo Ban; Wen-Miin Liang; Ying-Ju Lin
Journal:  BMC Complement Med Ther       Date:  2020-07-14

5.  Chrysophanol Prevents Lipopolysaccharide-Induced Hepatic Stellate Cell Activation by Upregulating Apoptosis, Oxidative Stress, and the Unfolded Protein Response.

Authors:  Jiunn-Sheng Wu; Valeria Chiu; Chou-Chin Lan; Ming-Chieh Wang; I-Shiang Tzeng; Chan-Yen Kuo; Po-Chun Hsieh
Journal:  Evid Based Complement Alternat Med       Date:  2020-07-04       Impact factor: 2.629

6.  Emodin alleviates hypertrophic scar formation by suppressing macrophage polarization and inhibiting the Notch and TGF-β pathways in macrophages.

Authors:  Zihuan Xia; Jiancheng Wang; Songlin Yang; Cheng Liu; Shu Qin; Wenbo Li; Yulong Cheng; Huan Hu; Jin Qian; Yi Liu; Chenliang Deng
Journal:  Braz J Med Biol Res       Date:  2021-07-23       Impact factor: 2.590

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.